Literature DB >> 35438004

Chloride channel accessory 1 gene deficiency causes selective loss of mucus production in a new pig model.

Shamus P Keeler1, Jennifer Yantis1, Benjamin J Gerovac1, Samuel L Youkilis1, Stephanie Podgorny1, Dailing Mao1, Yong Zhang1, Kristin M Whitworth2, Bethany Redel2, Melissa S Samuel2, Kevin D Wells2, Randall S Prather2, Michael J Holtzman1.   

Abstract

Morbidity and mortality of respiratory diseases are linked to airway obstruction by mucus but there are still no specific, safe, and effective drugs to correct this phenotype. The need for better treatment requires a new understanding of the basis for mucus production. In that regard, studies of human airway epithelial cells in primary culture show that a mucin granule constituent known as chloride channel accessory 1 (CLCA1) is required for inducible expression of the inflammatory mucin MUC5AC in response to potent type 2 cytokines. However, it remained uncertain whether CLCLA1 is necessary for mucus production in vivo. Conventional approaches to functional biology using targeted gene knockout were difficult due to the functional redundancy of additional Clca genes in mice not found in humans. We reasoned that CLCA1 function might be better addressed in pigs that maintain the same four-member CLCA gene locus and the corresponding mucosal and submucosal populations of mucous cells found in humans. Here we develop to our knowledge the first CLCA1-gene-deficient (CLCA1-/-) pig and show that these animals exhibit loss of MUC5AC+ mucous cells throughout the airway mucosa of the lung without affecting comparable cells in the tracheal mucosa or MUC5B+ mucous cells in submucosal glands. Similarly, CLCA1-/- pigs exhibit loss of MUC5AC+ mucous cells in the intestinal mucosa without affecting MUC2+ mucous cells. These data establish CLCA1 function for controlling MUC5AC expression as a marker of mucus production and provide a new animal model to study mucus production at respiratory and intestinal sites.

Entities:  

Keywords:  gene knockout; intestine; mucosa; mucous cells; pulmonary airway

Mesh:

Substances:

Year:  2022        PMID: 35438004      PMCID: PMC9142155          DOI: 10.1152/ajplung.00443.2021

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   6.011


  43 in total

1.  Group 2 Innate Lymphoid Cells Must Partner with the Myeloid-Macrophage Lineage for Long-Term Postviral Lung Disease.

Authors:  Kangyun Wu; Xinyu Wang; Shamus P Keeler; Benjamin J Gerovac; Eugene V Agapov; Derek E Byers; Susan Gilfillan; Marco Colonna; Yong Zhang; Michael J Holtzman
Journal:  J Immunol       Date:  2020-07-08       Impact factor: 5.422

2.  Paracellular Pathway-Mediated Mycoplasma hyopneumoniae Migration across Porcine Airway Epithelial Barrier under Air-Liquid Interface Conditions.

Authors:  Haiyan Wang; Zhenzhen Zhang; Xing Xie; Beibei Liu; Yanna Wei; Yuan Gan; Ting Yuan; Bo Ni; Jia Wang; Lei Zhang; Qiyan Xiong; Guoqing Shao; Zhixin Feng
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

3.  Genomic, tissue expression, and protein characterization of pCLCA1, a putative modulator of cystic fibrosis in the pig.

Authors:  Stephanie Plog; Lars Mundhenk; Nikolai Klymiuk; Achim D Gruber
Journal:  J Histochem Cytochem       Date:  2009-09-15       Impact factor: 2.479

4.  Colonic expression of MUC2, MUC5AC, and TFF1 in inflammatory bowel disease in children.

Authors:  Ron Shaoul; Yoshio Okada; Ernest Cutz; Margaret A Marcon
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-05       Impact factor: 2.839

5.  Abnormal expression of M1/MUC5AC mucin in distal colon of patients with diverticulitis, ulcerative colitis and cancer.

Authors:  Marie-Elisabeth Forgue-Lafitte; Bettina Fabiani; Pierre P Levy; Nicole Maurin; Jean-François Fléjou; Jacques Bara
Journal:  Int J Cancer       Date:  2007-10-01       Impact factor: 7.396

6.  Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology.

Authors:  James C Hogg; Fanny S F Chu; Wan C Tan; Don D Sin; Sanjay A Patel; Peter D Pare; Fernando J Martinez; Robert M Rogers; Barry J Make; Gerard J Criner; Reuben M Cherniack; Amir Sharafkhaneh; James D Luketich; Harvey O Coxson; W Mark Elliott; Frank C Sciurba
Journal:  Am J Respir Crit Care Med       Date:  2007-06-07       Impact factor: 21.405

7.  TREM-2 promotes macrophage survival and lung disease after respiratory viral infection.

Authors:  Kangyun Wu; Derek E Byers; Xiaohua Jin; Eugene Agapov; Jennifer Alexander-Brett; Anand C Patel; Marina Cella; Susan Gilfilan; Marco Colonna; Daniel L Kober; Tom J Brett; Michael J Holtzman
Journal:  J Exp Med       Date:  2015-04-20       Impact factor: 14.307

8.  The Goblet Cell Protein Clca1 (Alias mClca3 or Gob-5) Is Not Required for Intestinal Mucus Synthesis, Structure and Barrier Function in Naive or DSS-Challenged Mice.

Authors:  Nancy A Erickson; Elisabeth E L Nyström; Lars Mundhenk; Liisa Arike; Rainer Glauben; Markus M Heimesaat; André Fischer; Stefan Bereswill; George M H Birchenough; Achim D Gruber; Malin E V Johansson
Journal:  PLoS One       Date:  2015-07-10       Impact factor: 3.240

9.  Lawsonia intracellularis infection of intestinal crypt cells is associated with specific depletion of secreted MUC2 in goblet cells.

Authors:  Rebecca J Bengtsson; Neil MacIntyre; Jack Guthrie; Alison D Wilson; Heather Finlayson; Oswald Matika; Ricardo Pong-Wong; Sionagh H Smith; Alan L Archibald; Tahar Ait-Ali
Journal:  Vet Immunol Immunopathol       Date:  2015-08-19       Impact factor: 2.046

10.  IL-13-induced airway mucus production is attenuated by MAPK13 inhibition.

Authors:  Yael G Alevy; Anand C Patel; Arthur G Romero; Dhara A Patel; Jennifer Tucker; William T Roswit; Chantel A Miller; Richard F Heier; Derek E Byers; Tom J Brett; Michael J Holtzman
Journal:  J Clin Invest       Date:  2012-11-26       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.